References
- Cernes R, Mashavi M, Zimlichman R. Differential clinical profile of candesartan compared to other angiotensin receptor blockers. Vasc Health Risk Manag 2011; 7:749–759.
- Parving HH, Hendrik Lehnert H, Bröchner-Mortensen J, Gomis R, Andersen S, Arner P. The effect of Irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001; 345:870.
- Garcia-Touza M, Sowers JR. Evidence-based hypertension treatment in patients with diabetes. J Clin Hypertens (Greenwich) 2012; 14:97–102.
- Devereux RB, Dahlöf B. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. Curr Med Res Opin 2007; 23:443–457.
- Pfeffer MA, McMurray JJV, Velazquez EJ, Rouleau JL, Køber L, Maggioni AP, et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 2003; 349:1893–1906.
- Manfred Anlauf. Hemmstoffe des Renin-Angiotensin-Systems. In: Schwabe U, Paffrath D, eds. Arzneiverordnungs-Report 2011. Berlin, Heidelberg, New York: Springer-Verlag; 2011:226.
- Deters M, Bergmann I, Enden G, Kutz S, Liebetrau G, Plenert B, et al. Calcium channel antagonist exposures reported to the Poisons Information Center Erfurt. Eur J Intern Med 2011; 22:616–620.
- Balit CR, Gilmore SP, Isbister GK. Unintentional paediatric ingestions of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists. J Paediatr Child Health 2007; 43:686–688.
- Persson HE, Sjöberg GK, Haines JA, Pronczuk de Garbino J. Poisoning severity score. Grading of acute poisoning. Clin Toxicol 1998; 36:205–213.
- U.S. Department of Health & Human Services. Pediatric Basic and Advanced Life Support. Vital signs in children. Heart rate. http://www.chemm.nlm.nih.gov/pals.htm. Accessed March 1, 2013.
- Valentini M, Parati G. Variables influencing heart rate. Prog Cardiovasc Dis 2009; 52:11–19.
- Boer DP, de Rijke YB, Hop WC, Cransberg K, Dorresteijn EM. Reference values for serum creatinine in children younger than 1 year of age. Pediatr Nephrol 2010; 25:2107–2113.
- Finney H, Newman DJ, Price CP. Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann Clin Biochem 2000; 37:49–59.
- The Merck Manuals: The Merck Manual for Healthcare Professionals. Fever. http://www.merckmanuals.com/professional/sec14/ch167/ch167e.html. Accessed March 1, 2013.
- U.S. Department of Health & Human Services. Pediatric Basic and Advanced Life Support. Definition of Hypotension by Systolic Blood Pressure and Age. http://www.chemm.nlm.nih.gov/pals.htm. Accessed March 1, 2013.
- Hypotension. National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/dci/Diseases/hyp/hyp_whatis.html. Accessed March 1, 2013.
- Ram CV, Fenves A. Clinical pharmacology of antihypertensive drugs. Cardiol Clin 2002; 20:265–280.
- Forrester MB. Valsartan ingestions among adults reported to Texas poison control centers, 2000 to 2005. J Med Toxicol 2007; 3:157–163.